In addition, in preclinical stages, a combination of GLP-1R agonism with N-methyl-D-aspartate (NMDA) receptor antagonism (GLP-1-MK-801) has been developed [115]
Consult your provider before adding berberine
Learn more in the 2025 Employer Health Benefits Survey: To view or add a comment, sign in More Relevant Posts Will the White Houses recent deals to lower GLP-1 pricing impact employer health plans
To align costs and evidence, CVS standard template formularies (as of Feb 2024) made Wegovy and Saxenda its preferred agents among GLP-1s for obesity, relegating other anti-obesity drugs (Qsymia, orlistat, phentermine, etc.) to lower tiers ( [41] )
However, most of the PK studies demonstrated that the absorption characteristics of the oral drugs were not affected, therefore unsurprisingly, the co-exposure to a GLP1RA did not alter the AUC